Corient Private Wealth LP Invests $1.98 Million in Maximus, Inc. $MMS

Key Points

• Corient Private Wealth LP bought 36,910 Maximus shares in the second quarter, valued at approximately $1.98 million, giving it a 0.07% stake. Institutional investors collectively own 97.21% of the company.
• Maximus slightly exceeded quarterly earnings expectations with $2.22 in EPS, but revenue fell 5.1% year over year to $1.28 billion, below analyst estimates. Management issued fiscal 2026 EPS guidance of $7.90–$8.20.
• The company maintains a quarterly dividend of $0.33, equivalent to a 2.3% yield. Analyst sentiment has weakened, with coverage reflecting a consensus “Reduce” rating after downgrades to hold and strong sell.

Corient Private Wealth LP purchased a new position in shares of Maximus, Inc. (NYSE:MMS - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 36,910 shares of the health services provider's stock, valued at approximately $1,984,000. Corient Private Wealth LP owned about 0.07% of Maximus at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in MMS. Farther Finance Advisors LLC increased its position in Maximus by 69.0% during the 4th quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider's stock worth $25,000 after buying an additional 116 shares during the period. Advisory Services Network LLC acquired a new stake in shares of Maximus during the third quarter worth $32,000. Northwestern Mutual Wealth Management Co. boosted its position in shares of Maximus by 225.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 439 shares of the health services provider's stock valued at $38,000 after acquiring an additional 304 shares during the period. Canada Pension Plan Investment Board bought a new stake in shares of Maximus in the second quarter valued at about $35,000. Finally, Danske Bank A S acquired a new position in shares of Maximus in the third quarter valued at about $55,000. 97.21% of the stock is currently owned by institutional investors.

Maximus Stock Performance

NYSE:MMS opened at $57.67 on Thursday. The company has a market cap of $3.02 billion, a price-to-earnings ratio of 8.52 and a beta of 0.59. Maximus, Inc. has a fifty-two week low of $52.73 and a fifty-two week high of $100.00. The company has a debt-to-equity ratio of 0.90, a quick ratio of 2.42 and a current ratio of 2.42. The stock has a fifty day moving average price of $57.78 and a 200-day moving average price of $63.16.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The health services provider reported $2.22 EPS for the quarter, topping analysts' consensus estimates of $2.21 by $0.01. The company had revenue of $1.28 billion for the quarter, compared to analysts' expectations of $1.33 billion. Maximus had a return on equity of 24.91% and a net margin of 7.07%.Maximus's revenue was down 5.1% on a year-over-year basis. During the same quarter last year, the business earned $2.16 earnings per share. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. As a group, equities analysts anticipate that Maximus, Inc. will post 8.03 EPS for the current fiscal year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, August 31st. Shareholders of record on Friday, August 14th were issued a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend was Friday, August 14th. Maximus's dividend payout ratio (DPR) is currently 19.50%.

Analysts Set New Price Targets

A number of equities analysts recently commented on the stock. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Maximus in a research report on Monday, August 17th. Wall Street Zen downgraded shares of Maximus from a "buy" rating to a "hold" rating in a report on Saturday, August 8th. Finally, Zacks Research lowered shares of Maximus from a "hold" rating to a "strong sell" rating in a research report on Tuesday, August 11th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Reduce".

About Maximus

Maximus, Inc NYSE: MMS is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.